BE690024A - - Google Patents

Info

Publication number
BE690024A
BE690024A BE690024DA BE690024A BE 690024 A BE690024 A BE 690024A BE 690024D A BE690024D A BE 690024DA BE 690024 A BE690024 A BE 690024A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5123166A external-priority patent/GB1123770A/en
Application filed filed Critical
Priority claimed from CH1688066A external-priority patent/CH485693A/de
Publication of BE690024A publication Critical patent/BE690024A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
BE690024D 1963-11-29 1966-11-22 BE690024A (xx)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US327070A US3296255A (en) 1963-11-29 1963-11-29 2-cyano steroids
GB5123166A GB1123770A (en) 1966-11-15 1966-11-15 2-cyano-3-oxo-steroids
NL6616225A NL6616225A (xx) 1963-11-29 1966-11-17
FR84447A FR6368M (xx) 1963-11-29 1966-11-22
DE1966ST026144 DE1593564B2 (de) 1963-11-29 1966-11-23 2 alpha-cyan-4 alpha, 5 alpha-epoxy3-oxoandrostane und verfahren zu ihrer herstellung
CH1688066A CH485693A (de) 1966-11-24 1966-11-24 Verfahren zur Herstellung von 2a-Cyan-4a,5a-epoxy-3-oxo-steroiden

Publications (1)

Publication Number Publication Date
BE690024A true BE690024A (xx) 1967-05-22

Family

ID=27543910

Family Applications (1)

Application Number Title Priority Date Filing Date
BE690024D BE690024A (xx) 1963-11-29 1966-11-22

Country Status (5)

Country Link
US (1) US3296255A (xx)
BE (1) BE690024A (xx)
DE (1) DE1593564B2 (xx)
FR (1) FR6368M (xx)
NL (1) NL6616225A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4029776A (en) * 1975-12-19 1977-06-14 Sterling Drug Inc. Therapeutic composition and method of use thereof
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates
US4395423A (en) * 1978-10-10 1983-07-26 Sterling Drug Inc. Polycyclic cyanoketones
US4331663A (en) * 1981-06-19 1982-05-25 Sterling Drug Inc. 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
US4388311A (en) * 1982-05-06 1983-06-14 G. D. Searle & Co. Method for the induction of menses
ES526874A0 (es) * 1982-11-02 1985-05-01 Sterwin Ag Procedimiento de trituracion de compuestos esteroides
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
DK1919290T3 (da) 2005-07-12 2014-04-22 Ampio Pharmaceuticals Inc Fremgangsmåder og produkter til behandling af sygdomme
WO2018035079A1 (en) * 2016-08-16 2018-02-22 Hougland James L Human ghrelin o-acyl transferase inhibitors
CN115028674A (zh) * 2022-06-01 2022-09-09 山东沾化浩瀚药业有限公司 一种乳腺癌治疗药物曲洛司坦的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3035051A (en) * 1960-09-12 1962-05-15 American Cyanamid Co 2alpha-cyano or 2-hydroxymethylene-3-keto steroids
US3198790A (en) * 1962-05-12 1965-08-03 Ormonoterapia Richter Spa Steroidal dipyrimidines

Also Published As

Publication number Publication date
FR6368M (xx) 1968-10-14
DE1593564A1 (de) 1970-08-13
DE1593564B2 (de) 1976-04-22
US3296255A (en) 1967-01-03
NL6616225A (xx) 1968-05-20

Similar Documents

Publication Publication Date Title
AR142945A1 (xx)
FR6368M (xx)
FR3956M (xx)
AT260747B (xx)
BE627012A (xx)
BE616967A (xx)
BE626986A (xx)
BE645701A (xx)
BE31062A (xx)
BE462764A (xx)
BE465565A (xx)
BE507458A (xx)
BE533484A (xx)
BE547422A (xx)
BE571209A (xx)
BE582314A (xx)
BE603935A (xx)
BE608372A (xx)
BE612803A (xx)
BE614220A (xx)
BE645188A (xx)
BE616830A (xx)
BE626358A (xx)
BE619061A (xx)
BE620325A (xx)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: STERLING DRUG INC.

Effective date: 19861122